Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine
 Disease Category: Fallopian Tube Cancer
Location: United States, NY

Trial Information

Ovarian/Fallopian/Primary Peritoneal Cancer

Adults with primary peritoneal, ovarian or fallopian tube cancer are asked to participate in a research study of an investigational medication being conducted by Mount Sinai School of Medicine.

You may be eligible to participate in this study if you:

  • Are a female 18 years of age or older
  • Have documented invasive epithelial ovarian, primary peritoneal, or fallopian tube cancer
  • Have a life expectancy greater than 3 months

You may not participate in this study if you:

  • Have received more than 3 previous treatments of anti-cancer therapy for epithelial ovarian, primary peritoneal, or fallopian tube cancer
  • Have had major surgery within 28 days prior to starting this study
  • Have uncontrolled high blood pressure
  • Have a history of allergic reaction to certain proteins (as determined by the study doctor)

Rosemary Wein, Study Coordinator
Biomedical Research Alliance of New York
Mount Sinai School of Medicine,
1176 5th Avenue, Box 1170,
New York, NY 10016
Phone: 646-319-0497
Fax: 212-987-6386
Email: rosemary.wein@mssm.edu

View Map

Research Center Information: Biomedical Research Alliance of New York

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.